WDB coco Co (TSE:7079) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7079 WDB coco Co Ltd TSE:7079
72 GF Score
Price 円2,636.00
GF Value 円3,468.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WDB coco Co FFO per Share?

FFO per Share only applies to REITs.

TSE:7079
72GF Score
WDB coco Co Ltd TSE:7079
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is WDB coco Co (TSE:7079) Overvalued in 2026?

Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued. The current stock price of 円2,636.00 is trading 24% below its estimated GF Value™ of 円3,468.55. GuruFocus considers WDB coco Co to be Modestly Undervalued.

Key valuation signals for TSE:7079:

  • FFO per Share:
  • GF Value™: 円3,468.55 vs. price of 円2,636.00 (24% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WDB coco Co Business Description

Address 1-8-11 Harumi, Chuo-ku, Triton Square Y Building, 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
72GF Score

Get the complete analysis for TSE:7079

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,636.00
Price
円3,468.55
GF Value